Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZG34
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,573
Award facts
- Contract value 100% obligated
- $46,573.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 200 unit vials valued at $46,573.20 with a firm fixed-price contract structure. The award was issued on September 26, 2025, with an ultimate completion date of October 20, 2025, and does not include a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with a reliable supply of pharmaceuticals and medical consumables to support military healthcare facilities worldwide. As a regional prime vendor contractor under this program, DMS Pharmaceutical Group supplies a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to federal military medical facilities. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FZG34?
SPE2DB25FZG34 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FZG34 worth?
The government has obligated $46,573 on SPE2DB25FZG34.
Is contract SPE2DB25FZG34 an order under another contract?
Yes. SPE2DB25FZG34 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG34 competed?
The extent of competition for SPE2DB25FZG34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award